Dolca Thomas's Net Worth
$2.03 Million
Who is Dolca Thomas?
Dolca Thomas has an estimated net worth of $2.03 Million. This is based on reported shares across multiple companies, which include CHINOOK THERAPEUTICS, INC., Equillium, Inc., Principia Biopharma Inc., and Allakos Inc..
SEC CIK
Dolca Thomas's CIK is 0001768239
Past Insider Trading and Trends
2020 was Dolca Thomas's most active year for acquiring shares with 4 total transactions. Dolca Thomas's most active month to acquire stocks was the month of April. 2020 was Dolca Thomas's most active year for disposing of shares, totalling 8 transactions. Dolca Thomas's most active month to dispose stocks was the month of July. 2020 saw Dolca Thomas paying a total of $713,100.00 for 108,522 shares, this is the most they've acquired in one year. In 2020 Dolca Thomas cashed out on 345,264 shares for a total of $2,921,769.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CHINOOK THERAPEUTICS, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -13.30K |
—
|
—
|
0
|
Aug 11
| |||
Form 4
| +33.00% | 3.3K |
—
|
—
| 13.3K |
May 26
| |||
Form 4
|
∞
| 10K |
$21.22 | $212,194.00 | 10K |
Sep 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Equillium, Inc. (EQ) Snapshot price: $1.445
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.21K |
$100.00 | -$220,700.00 |
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
$61.89 | -$1,143,450.00 | 1.83K |
Scheduled
|
Aug 18
| ||
Form 4
|
—
|
0
|
$51.92 | -$844,519.50 | 1.83K |
Scheduled
|
Jul 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| -50.05% | -495.00 |
$60.00 | -$29,700.00 | 494 |
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allakos Inc. (ALLK) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||